A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Olaparib Combined With Cisplatin-based Chemoradiotherapy to Treat Locally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
- Status
- RECRUITING
- Phase
- PHASE3
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy
- Status
- WITHDRAWN
- Phase
- NA
The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration.
- Status
- UNKNOWN
- Phase
- PHASE3
Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers
- Status
- COMPLETED
- Phase
- PHASE3
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
- Status
- TERMINATED
- Phase
- NA
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
- Status
- TERMINATED
- Phase
- PHASE2